Showing 1841-1850 of 3038 results for "".
- New Open Access Ophthalmology Journal Now Livehttps://modernod.com/news/new-open-access-ophthalmology-journal-now-live/2478998/Ophthalmology Science—the American Academy of Ophthalmology’s first open access journal—is now live and accepting submissions. Ophthalmology Science is an online open access journal focused on publishing preclinical development, phase 1 and 2 clinical trials, laboratory
- National Eye Institute Launches Data Portal for Macular Degeneration Researchhttps://modernod.com/news/national-eye-institute-launches-data-portal-for-macular-degeneration-research/2478992/The National Eye Institute (NEI) Data Commons now enables researchers to access data from patients with macular degeneration who participated in the Age-related Eye Disease
- NovaSight Announces First Pivotal Study for Lazy-Eye Digital Treatment Against Gold Standard Patchinghttps://modernod.com/news/novasight-announces-first-pivotal-study-for-lazy-eye-digital-treatment-against-gold-standard-patching/2478980/Israeli startup NovaSight has announced that it is running a large, pivotal multicenter randomized controlled trial to assess the safety and effectiveness of an eye-tracking-based treatment for amblyopia (lazy eye). This is the first pivotal study of its kind in children against the gold standard
- Magewell Video Capture Devices Help Non-Profit Eyecare Organization Remotely Train Retinal Surgeons Worldwidehttps://modernod.com/news/magewell-video-capture-devices-help-non-profit-eyecare-organization-remotely-train-retinal-surgeons-worldwide/2478975/Telemedicine workflows incorporating live video have taken on dramatically greater importance for surgical education during the COVID-19 pandemic, as doctors reduce non-essential personnel in their operating rooms for the safety of patients and staff. Needing a way to continue its mission of impr
- Researchers Develop New Noninvasive Technique to Image Human Eyehttps://modernod.com/news/researchers-develop-new-noninvasive-technique-to-image-human-eye/2478947/Researchers have developed a noninvasive technique that can capture images of rod and cone photoreceptors with unprecedented detail. The advance could lead to new treatments and earlier detection for retinal diseases such as macular degeneration, according to a National Eye Institute news release
- Hydrus Microstent Now First MIGS Device With 5-Year Pivotal Trial Datahttps://modernod.com/news/hydrus-microstent-now-first-migs-device-with-5-year-pivotal-trial-data/2478937/Ivantis, developer of the novel Hydrus Microstent, announced the first release of 5-year follow-up data from its HORIZON pivotal trial. This milestone represents the longest continuous follow-up of a MIGS device pivotal trial. The 5-year HORIZON data demonstrated the Hydrus Microstent̵
- Zubisoft Launches New Nomogram and Laser Treatment Planner for Zeiss SMILEhttps://modernod.com/news/zubisoft-launches-new-nomogram-and-laser-treatment-planner-for-zeiss-smile/2478920/Swiss-based Zubisoft has developed the IBRA nomogram calculator, designed to allow refractive surgeons to optimize treatment planning for small incision lenticular extraction with the Zeiss VisuMax femto laser platfor
- FCI Ophthalmics Announces Availability of LacriJet for Monocanalicular Nasolacrimal Intubationhttps://modernod.com/news/fci-ophthalmics-announces-availability-of-lacrijet-for-monocanalicular-nasolacrimal-intubation/2478907/FCI Ophthalmics announced the launch of the LacriJet in the United States. It is the first, self-retaining monocanalicular nasolacrimal intubation preloaded on a single use injector, according to FCI Ophthalmics. LacriJet consists of a single use injector handpiece into which a silicone tu
- Asclepix Therapeutics Partners With Notal Vision on Home OCT Remote Monitoring in DME and AMD Clinical Trialshttps://modernod.com/news/asclepix-therapeutics-partners-with-notal-vision-on-home-oct-remote-monitoring-in-dme-and-amd-clinical-trials/2478900/Notal Vision announced that the company will provide AsclepiX Therapeutics with Home OCT monitoring services through its Notal Vision Diagnostic Clinic to support AsclepiX’s AXT107 phase 1 clinical trial program. The
- Nicox Announces the Publication of Preclinical Efficacy Results on a New Class of Non-PGA NO-Donating IOP-Lowering Compoundshttps://modernod.com/news/nicox-announces-the-publication-of-preclinical-efficacy-results-on-a-new-class-of-non-pga-no-donating-iop-lowering-compounds/2478896/Nicox SA announced the publication of preclinical IOP-lowering results on a new class of non-prostaglandin analog (PGA), nitric oxide (NO)-donating compounds, in the Journal of Ocular Pharmacology and Therapeutics.1 The NO-mediated IOP-lowering effect in this new class of comp